Skip to main content
Clinical Trials/IRCT2017012832249N1
IRCT2017012832249N1
Recruiting
未知

Positive airway pressure (PAP) therapy and its impact on the components of metabolic syndrome in obstructive sleep apnea (OSA) patients

Vice chancellor for research, Tehran University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Obstructive Sleep Apnea.
Sponsor
Vice chancellor for research, Tehran University of Medical Sciences
Enrollment
40
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Tehran University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria consist of adult patients with OSA and clinical indication for PAP therapy. Exclusion criteria consist of pregnancy, cardiopulmonary disorder, upper airway cancer or surgery, change or new administration of drug for hyperlipidemia, hypertension and diabetes mellitus.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials